Object's details: Comparative Effectiveness of Risankizumab vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes after Inadequate Response to Prior Therapy

Similar objects

tile.noImage
tile.noImage
tile.noImage
tile.noImage
tile.noImage
tile.noImage
tile.noImage
tile.noImage
We use files, through the cookie quality improvement layer of our website.For more information, please read the document Privacy Policy